Latest Blogs, Articles, and More View More >>
Rolling submission of a new drug application for rociletinib has been initiated for patients with EGFR T790M-positive metastatic NSCLC following prior treatment with an EGFR-targeted therapy.
The President's Cancer Panel is looking for ways to improve connected health for cancer patients. What are your recommendations?
Living on the top floor with cancer.
Breast cancer and melanoma survivor Barbara Tako introduces herself.
Does sugar cause cancer? Does sugar feed cancer?
Eleanor Miller, a nurse at the University of Pennsylvania, writes about considerations for a patient who is pregnant with a breast cancer diagnosis.
A single intravenous dose of EMEND for Injection was shown to be superior to placebo when either were combined with other anti-vomiting agents for protection against CINV in patients receiving moderately emetogenic chemotherapy.